May 2026– date –
-
CellFiber and Locus Cell Establish Commercial-Scale Manufacturing for Human Umbilical Cord-Derived Mesenchymal Stem Cells Using Advanced 3D Culture Technology
PR TIMES Japan Overview Japan's CellFiber and its Taiwanese partner Locus Cell have successfully established a commercial-scale manufacturing process for human umbilical cord-derived mesenchymal stem cells (UC-MSC) utilizing the innovati... -
South Korean Biotech Giants Diverge: Samsung Biologics Faces Labor Risks Amid Record Growth, Celltrion Boosts Global CDMO Expansion
aju press South Korea Overview South Korea's leading biotech firms, Samsung Biologics and Celltrion, show divergent paths: Samsung Biologics achieved record Q1 2026 performance with 25.8% revenue growth due to full plant utilization but ... -
Cytiva’s ELEVECTA Cell Line Receives FDA AMT Designation, Pioneering Next-Gen AAV Manufacturing with 99% Host Cell DNA Reduction
BioPharma BoardRoom USA Overview Cytiva, a Danaher company, has secured FDA Advanced Manufacturing Technology (AMT) designation for its ELEVECTA transient cell line, designed for adeno-associated virus (AAV) manufacturing. This pioneerin... -
Roche and NVIDIA Launch AI Factory with Omniverse Digital Twins to Optimize GLP-1 Pharma Manufacturing
IntuitionLabs USA Overview Roche has partnered with NVIDIA to establish a 3,500+ GPU AI factory, deploying Omniverse digital twins for an upcoming GLP-1 manufacturing facility. This initiative integrates AI and simulation to optimize ent... -
Swiss Biotech Bioscibex Begins Shipments of Novel SW1NGO Single-Use Bioreactor-Incubators, Streamlining Bioprocess Seed Trains
Startupticker.ch Switzerland Overview Swiss biopharmaceutical startup Bioscibex has begun delivering its innovative SW1NGO single-use bioreactor-incubators to initial customers, marking a significant milestone. This system is designed to... -
Aldevron and Minaris Renew Lentiviral Plasmid Agreement, Bolstering Critical Supply for Advanced Cell and Gene Therapies
BioBuzz USA Overview Aldevron and Minaris have renewed their lentiviral plasmid licensing agreement, significantly expanding access to scalable plasmid solutions essential for advanced cell and gene therapy (CGT) developers. This collabo... -
CDMO Sector Sees Strategic Expansions: Andelyn Biosciences Launches LVV Platform, Made Scientific Partners with RoosterBio
DCAT Value Chain Insights USA Overview The biopharmaceutical contract development and manufacturing (CDMO) sector is experiencing significant strategic advancements, with Andelyn Biosciences unveiling its 'LVV curator platform' for stand... -
Advanced PCR Strategies Critical for Precision and Safety in Cell and Gene Therapy Development
Biocompare USA Overview Polymerase Chain Reaction (PCR) technologies are pivotal across the entire lifecycle of cell and gene therapy (CGT) product development, from early gene target validation to comprehensive quality and safety assess... -
Meatly Secures $14M Series A to Build Europe’s Largest Cultivated Meat Facility in London
Green Queen Media UK Overview British food tech firm Meatly has raised £10 million ($14.1 million) in Series A funding to construct a 20,000-liter cultivated meat pilot plant in London, set to become Europe's largest. The company, which ... -
Industrializing Cell & Gene Therapy Manufacturing: Key Takeaways from Advanced Therapies USA Conference
BioProcess International USA Overview The Advanced Therapies USA conference highlighted the critical shift in cell and gene therapy (CGT) manufacturing towards large-scale industrialization through process consolidation, closed automatio...
